ChronoScale Corporation Common Stock (NASDAQ:CHRN) Share Price Crosses Above 50-Day Moving Average – Here’s Why

ChronoScale Corporation Common Stock (NASDAQ:CHRN) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $13.84 and traded as high as $17.66. ChronoScale Corporation Common Stock shares last traded at $17.41, with a volume of 402,143 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, ChronoScale Corporation Common Stock presently has a consensus rating of “Reduce” and a consensus price target of $6.00.

ChronoScale Corporation Common Stock Price Performance

The stock’s 50-day moving average price is $13.84 and its 200-day moving average price is $10.33. The company has a market capitalization of $61.98 million, a price-to-earnings ratio of -3.24 and a beta of 1.02. The company has a quick ratio of 1.03, a current ratio of 1.55 and a debt-to-equity ratio of 0.25.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings results on Tuesday, April 28th. The company reported ($2.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($2.01). The business had revenue of $2.14 million for the quarter, compared to the consensus estimate of $4.29 million. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. Equities research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Roble Belko & Company Inc boosted its holdings in ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after purchasing an additional 1,195 shares during the last quarter. Virtu Financial LLC acquired a new position in ChronoScale Corporation Common Stock during the third quarter worth $57,000. Shay Capital LLC acquired a new position in ChronoScale Corporation Common Stock during the third quarter worth $67,000. Citadel Advisors LLC acquired a new position in ChronoScale Corporation Common Stock during the third quarter worth $198,000. Finally, Geode Capital Management LLC boosted its holdings in ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares during the last quarter. Institutional investors and hedge funds own 6.42% of the company’s stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.